3M (NYSE: MMM) EVP exercises options, then sells 7,669 shares
Rhea-AI Filing Summary
3M executive Kevin H. Rhodes, EVP and Chief Legal Officer, reported exercising a non-qualified stock option for 7,669 shares of common stock on July 22, 2026 at an exercise price of $154.6900 per share. He then sold 7,669 shares of common stock at $171.2000 per share the same day. The option, originally granted on February 7, 2018 and expiring February 6, 2027, now shows zero remaining derivative shares, and the transactions were not made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 7,669 shares ($127K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Rhodes Kevin H
Role
EVP, Chief Legal Off & Secret
Sold
7,669 shs ($1.31M)
Approx. gross sale proceeds
$1.31M
Approx. exercise cost
$1.19M
Approx. pre-tax spread
$127K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-qualified Stock Option (Right to Buy) | 7,669 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,669 | $154.69 | $1.19M |
| Sale | Common Stock F1 | 7,669 | $171.20 | $1.31M |
Holdings After Transaction:
Non-qualified Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 43,779.9933 shares (Direct)
Footnotes (1)
- F1. Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan.
Key Figures
Options exercised: 7,669 shares
Exercise price: $154.6900 per share
Common shares sold: 7,669 shares
+4 more
7 metrics
Options exercised
7,669 shares
Non-qualified stock option exercised on July 22, 2026
Exercise price
$154.6900 per share
Exercise price of the non-qualified stock option
Common shares sold
7,669 shares
Common stock sold on July 22, 2026
Sale price
$171.2000 per share
Per-share price for the reported common stock sale
Option grant date
February 7, 2018
Grant date of the exercised non-qualified stock option
Option expiration
February 6, 2027
Expiration date associated with the exercised option grant
Net shares sold
7,669 shares
Net sell direction across reported Form 4 transactions
Key Terms
Non-qualified Stock Option (Right to Buy), Deferred Compensation Plan, dividend share equivalents
3 terms
Non-qualified Stock Option (Right to Buy) financial
"Security title listed as Non-qualified Stock Option (Right to Buy)"
Deferred Compensation Plan financial
"pursuant to 3M's Deferred Compensation Plan"
A deferred compensation plan is an arrangement where an employer agrees to pay part of an employee’s pay or bonus at a later date instead of immediately, often to reduce current tax bills or to tie rewards to long-term performance. For investors it matters because these promises create future cash obligations and influence executive incentives and retention; they can affect a company’s reported liabilities, cash flow planning and the risk profile if the business faces financial trouble.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did 3M (MMM) executive Kevin H. Rhodes report?
Kevin H. Rhodes reported exercising 7,669 non-qualified stock options and selling 7,669 shares of 3M common stock. Both the option exercise and the share sale occurred on July 22, 2026, according to the Form 4 insider filing.
How many 3M (MMM) options did Kevin H. Rhodes exercise in this Form 4?
He exercised a non-qualified stock option covering 7,669 shares of 3M common stock. The option was originally granted on February 7, 2018 and carried an expiration date of February 6, 2027 before being fully exercised.
Were Kevin H. Rhodes’s 3M (MMM) transactions under a Rule 10b5-1 plan?
The filing indicates the transactions were not made pursuant to a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is explicitly unchecked, meaning no pre-arranged trading plan is affirmed for these reported trades.
What does the Form 4 say about remaining 3M (MMM) options after Rhodes’s exercise?
The non-qualified stock option for 7,669 shares shows 0 derivative shares remaining after the July 22, 2026 exercise. This indicates the reported option grant tied to these transactions has been fully exercised and no longer represents an outstanding derivative position.